Home LiteratureArticle Details
PMID: 11331884 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway.

Nature cell biology ·Vol. 3 ·No. 5 ·2001-05-00 ·Pages 527-30

Miao H, Wei BR, Peehl DM, Li Q, Alexandrou T, Schelling JR, Rhim JS, Sedor JR, Burnett E, Wang B

Abstract

Interactions between Eph receptor tyrosine kinases (RTKs) and membrane-anchored ephrin ligands critically regulate axon pathfinding and development of the cardiovascular system, as well as migration of neural cells. Similar to other RTKs, ligand-activated Eph kinases recruit multiple signalling and adaptor proteins, several of which are involved in growth regulation. However, in contrast to other RTKs, activation of Eph receptors fails to promote cell proliferation or to transform rodent fibroblasts, indicating that Eph kinases may initiate signalling pathways that are distinct from those transmitted by other RTKs. Here we show that stimulation of endogenous EphA kinases with ephrin-A1 potently inhibits the Ras/MAPK cascade in a range of cell types, and attenuates activation of mitogen-activated protein kinase (MAPK) by receptors for platelet-derived growth factor (PDGF), epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF). In prostatic epithelial cells and endothelial cells, but not fibroblasts, treatment with ephrin-A1 inhibits cell proliferation. Our results identify EphA kinases as negative regulators of the Ras/MAPK pathway that exert anti-mitogenic functions in a cell-type-specific manner.

MeSH Terms
Animals Cell Division Cell Line Endothelial Growth Factors/metabolism Enzyme Activation Enzyme Inhibitors/pharmacology Ephrin-A1 Epidermal Growth Factor/metabolism Fibroblasts/metabolism Humans Immunoblotting Keratinocytes/metabolism Lymphokines/metabolism MAP Kinase Signaling System Male Mitogen-Activated Protein Kinase 1/antagonists & inhibitors Mitogen-Activated Protein Kinase 3 Mitogen-Activated Protein Kinases/antagonists & inhibitors Platelet-Derived Growth Factor/metabolism Precipitin Tests Prostatic Neoplasms/metabolism Proteins/metabolism Rats Receptor Protein-Tyrosine Kinases/metabolism Receptor, EphA1 Receptor, EphA2 Signal Transduction Time Factors Tumor Cells, Cultured Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors ras Proteins/antagonists & inhibitors,metabolism
Chemicals
Endothelial Growth Factors Enzyme Inhibitors Ephrin-A1 Lymphokines Platelet-Derived Growth Factor Proteins Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors Epidermal Growth Factor Receptor Protein-Tyrosine Kinases Receptor, EphA1 Receptor, EphA2 Mitogen-Activated Protein Kinase 1 Mitogen-Activated Protein Kinase 3 Mitogen-Activated Protein Kinases ras Proteins
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Miao H
Rammelkamp Center for Research, MetroHealth Campus, Case Western Reserve University School of Medicine, 2500 MetroHealth Drive, Cleveland, Ohio 44109 USA.
Wei B R
Peehl D M
Li Q
Alexandrou T
Schelling J R
Rhim J S
Sedor J R
Burnett E
Wang B
Article Info
Journal
Nature cell biology
Abbr.
Nat Cell Biol
ISSN
1465-7392
Published
2001-05-00
Pages
527-30
Language
English
Region
England
NLM ID
100890575
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]